OAC
OMERS Administration Corp Portfolio holdings
AUM
$12.7B
1-Year Return
22.78%
This Quarter Return
-2.69%
1 Year Return
+22.78%
3 Year Return
+71.29%
5 Year Return
+144.31%
10 Year Return
+293.75%
AUM
$11.4B
AUM Growth
-$5.94M
(-0.05%)
Cap. Flow
+$480M
Cap. Flow
% of AUM
4.2%
Top 10 Holdings %
Top 10 Hldgs %
33.97%
Holding
1,167
New
212
Increased
341
Reduced
392
Closed
141
Top Buys
| 1 |
Eaton
ETN
|
+$112M |
| 2 |
Salesforce
CRM
|
+$112M |
| 3 |
Duke Energy
DUK
|
+$105M |
| 4 |
Eli Lilly
LLY
|
+$99.8M |
| 5 |
Toronto Dominion Bank
TD
|
+$75.2M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$135M |
| 2 |
Exxon Mobil
XOM
|
+$111M |
| 3 |
Elevance Health
ELV
|
+$53.1M |
| 4 |
TJX Companies
TJX
|
+$42.1M |
| 5 |
ServiceNow
NOW
|
+$30.5M |
Sector Composition
| 1 | Technology | 24.87% |
| 2 | Financials | 19.66% |
| 3 | Industrials | 11.21% |
| 4 | Healthcare | 9.16% |
| 5 | Consumer Discretionary | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Olo Inc
OLO
$1.74B
| $348K | ﹤0.01% |
+57,600
| New | +$348K |
|
827
Rezolute
RZLT
$703M
| $345K | ﹤0.01% |
118,900
+42,900
| +56% | +$124K |
|
|
NESR
828
National Energy Services Reunited Corp. Ordinary Shares
NESR
$973M
| $344K | ﹤0.01% |
46,700
+14,900
| +47% | +$110K |
|
829
Abeona Therapeutics
ABEO
$350M
| $344K | ﹤0.01% |
72,200
+7,155
| +11% | +$34.1K |
|
830
Zevia
ZVIA
$187M
| $340K | ﹤0.01% |
157,300
+68,800
| +78% | +$149K |
|
831
Huntington Ingalls Industries
HII
$10.5B
| $338K | ﹤0.01% |
1,656
-4,200
| -72% | -$857K |
|
832
Teva Pharmaceuticals
TEVA
$22.6B
| $337K | ﹤0.01% |
21,947
| – | – |
|
833
Gevo
GEVO
$389M
| $336K | ﹤0.01% |
289,300
+154,400
| +114% | +$179K |
|
834
Weis Markets
WMK
$1.76B
| $331K | ﹤0.01% |
+4,300
| New | +$331K |
|
835
eHealth
EHTH
$119M
| $330K | ﹤0.01% |
49,400
+7,727
| +19% | +$51.6K |
|
836
Monopar Therapeutics
MNPR
$277M
| $328K | ﹤0.01% |
+9,000
| New | +$328K |
|
|
HUYA
837
Huya Inc
HUYA
$783M
| $325K | ﹤0.01% |
+101,200
| New | +$325K |
|
838
Instil Bio
TIL
$172M
| $325K | ﹤0.01% |
+18,700
| New | +$325K |
|
839
Innovative Industrial Properties
IIPR
$1.59B
| $325K | ﹤0.01% |
+6,000
| New | +$325K |
|
840
Douglas Elliman
DOUG
$240M
| $323K | ﹤0.01% |
187,700
+23,900
| +15% | +$41.1K |
|
841
Standex International
SXI
$2.41B
| $323K | ﹤0.01% |
+2,000
| New | +$323K |
|
842
Lamb Weston
LW
$7.96B
| $322K | ﹤0.01% |
6,033
-11,800
| -66% | -$629K |
|
843
Nuvectis Pharma
NVCT
$161M
| $321K | ﹤0.01% |
+32,882
| New | +$321K |
|
844
Protara Therapeutics
TARA
$120M
| $320K | ﹤0.01% |
+75,100
| New | +$320K |
|
845
Henry Schein
HSIC
$8.2B
| $317K | ﹤0.01% |
4,634
-769
| -14% | -$52.7K |
|
846
Ironwood Pharmaceuticals
IRWD
$180M
| $316K | ﹤0.01% |
215,110
| – | – |
|
847
Veritone
VERI
$212M
| $315K | ﹤0.01% |
+135,600
| New | +$315K |
|
848
Dayforce
DAY
$10.9B
| $313K | ﹤0.01% |
5,373
-902
| -14% | -$52.6K |
|
849
First United
FUNC
$237M
| $312K | ﹤0.01% |
+10,400
| New | +$312K |
|
850
Skillsoft
SKIL
$129M
| $308K | ﹤0.01% |
+16,000
| New | +$308K |
|